Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Rotstein

Ado-Trastuzumab Emtansine Targets Hepatocytes via Human Epidermal Growth Factor Receptor 2 to Induce Hepatotoxicity

Molecular Cancer Therapeutics

Cancer Research

Oncology

2015

English

Multiple Sclerosis Fatigue Is Associated With Reduced Psychomotor Vigilance

Canadian Journal of Neurological Sciences

Medicine

Neurology

2012

English

Related publications

Human Epidermal Growth Factor 2 (HER2) Non-Small Cell Lung Cancer (NSCLC) With YVMA Mutation Responsive to Ado-Trastuzumab Emtansine

Journal of Case Reports and Images in Oncology

2020

English

Substituting Adjuvant Trastuzumab Emtansine for Herceptin Improves Survival in Patients With Human Epidermal Growth Factor Receptor 2–positive Breast Cancer

English

Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: A Meta-Analysis

Scientific Reports

Multidisciplinary

2016

English

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab With Taxane for Human Epidermal Growth Factor Receptor 2–positive Advanced Breast Cancer: Final Results From MARIANNE

English

Feasibility and Cardiac Safety of Trastuzumab Emtansine After Anthracycline-Based Chemotherapy as (Neo)Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer

Journal of Clinical Oncology

English

Helicobacter pyloriCan Induce Heparin-Binding Epidermal Growth Factor Expression via Gastrin and Its Receptor

Cancer Research

Oncology

2006

English

Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer

Expert Opinion on Biological Therapy

Drug Discovery

Clinical Biochemistry

Pharmacology

2013

English

FEN1 Knockdown Improves Trastuzumab Sensitivity in Human Epidermal Growth Factor 2‑positive Breast Cancer Cells

Experimental and Therapeutic Medicine

English

Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Rotstein

Ado-Trastuzumab Emtansine Targets Hepatocytes via Human Epidermal Growth Factor Receptor 2 to Induce Hepatotoxicity

Multiple Sclerosis Fatigue Is Associated With Reduced Psychomotor Vigilance

Related publications

Human Epidermal Growth Factor 2 (HER2) Non-Small Cell Lung Cancer (NSCLC) With YVMA Mutation Responsive to Ado-Trastuzumab Emtansine

Substituting Adjuvant Trastuzumab Emtansine for Herceptin Improves Survival in Patients With Human Epidermal Growth Factor Receptor 2–positive Breast Cancer

Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: A Meta-Analysis

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab With Taxane for Human Epidermal Growth Factor Receptor 2–positive Advanced Breast Cancer: Final Results From MARIANNE

Feasibility and Cardiac Safety of Trastuzumab Emtansine After Anthracycline-Based Chemotherapy as (Neo)Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer

Helicobacter pyloriCan Induce Heparin-Binding Epidermal Growth Factor Expression via Gastrin and Its Receptor

Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer

FEN1 Knockdown Improves Trastuzumab Sensitivity in Human Epidermal Growth Factor 2‑positive Breast Cancer Cells

Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer